Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial–mesenchymal transition
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial–mesenchymal transition
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 15, Pages 1888-1898
Publisher
Springer Nature
Online
2015-07-06
DOI
10.1038/onc.2015.258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients
- (2014) A. K. Reka et al. CARCINOGENESIS
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
- (2011) W. Hu et al. CANCER RESEARCH
- rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia
- (2011) X. Ge et al. CLINICAL CANCER RESEARCH
- Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System
- (2011) B. A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Identifying Inhibitors of Epithelial-Mesenchymal Transition by Connectivity Map–Based Systems Approach
- (2011) Ajaya Kumar Reka et al. Journal of Thoracic Oncology
- Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
- (2010) Yi-Fan Hsu et al. Molecular Cancer
- Peroxisome Proliferator-Activated Receptor- Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition
- (2010) A. K. Reka et al. MOLECULAR CANCER THERAPEUTICS
- EMT: When epithelial cells decide to become mesenchymal-like cells
- (2009) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Temporal Quantitative Proteomics by iTRAQ 2D-LC-MS/MS and Corresponding mRNA Expression Analysis Identify Post-Transcriptional Modulation of Actin-Cytoskeleton Regulators During TGF-β-Induced Epithelial-Mesenchymal Transition
- (2009) Venkateshwar G. Keshamouni et al. JOURNAL OF PROTEOME RESEARCH
- Is complement good or bad for cancer patients? A new perspective on an old dilemma
- (2009) Maciej M. Markiewski et al. TRENDS IN IMMUNOLOGY
- Epithelial-Mesenchymal Transition
- (2008) J. Zavadil et al. CANCER RESEARCH
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search